Search results
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
Fortune· 3 days agoThe company, which generated $45.8 billion in revenue last year, will launch 20 new medicines by the end of the decade to meet the new total revenue target, Astra said Tuesday. The revenue goal ...
Promethium Discovery Set to Rewrite Chemistry Textbooks
SciTechDaily· 1 hour agoScientists have made a significant breakthrough in understanding the properties of promethium, a...
The price of hope: CAR-T therapy in pediatric leukemia
Medical Xpress· 3 days agoWe stand at the crossroads of medical innovation, where cutting-edge scientific discoveries...
Immune-checkpoint inhibitors protect bone by promoting osteogenesis, exploratory study shows
Medical Xpress· 2 days agoImmune checkpoint inhibitors (ICIs), widely employed anticancer agents, have been found to impact...
Studies Reveal Cell-by-Cell Changes Caused When Pig Hearts and Kidneys are Transplanted into Humans
CBS 47 Fresno· 3 days agoDemonstrating the field's progress, NYU Langone in April 2024 transplanted a pig kidney into a living patient. Now two new analyses, one published online on May 17 in Nature Medicine and the ...
Ultra-processed foods linked to higher cognitive decline, stroke risk
MedicalNewsToday via AOL· 3 hours agoA new study published this week from researchers at Massachusetts General Hospital in Boston finds...
Ultra-processed foods: Study finds link to cognitive decline, stroke
Medical News Today· 3 hours agoA recent study linked eating ultra-processed foods to an increased risk for 32 adverse health...
Could a new Alzheimer's biomarker help diagnose the disease before symptoms show?
MedicalNewsToday via AOL· 4 days agoMore diagnostic tools for early-stage Alzheimer’s needed MNT also spoke with Manisha Parulekar,...
Nuclear medicine booms in central Indiana - Indianapolis Business Journal
Indianapolis Business Journal· 7 days agoWhat’s inside, when the project is completed, will be large commercial batches of actinium 225, an...
Quadruple Therapies and the Future of Multiple Mye | Newswise
Newswise· 23 hours agoMIAMI, FLORIDA – The treatment landscape for multiple myeloma, the second most common blood cancer,...